A study identifies microbes that potentially play important roles in breaking down harmful PFAS chemicals and points to functional genes that may be involved.
Dr. Jennifer Downs of Weill Cornell Medicine is collaborating with Tanzanian researchers to treat schistosomiasis, a parasitic worm infection affecting 250 million people worldwide.
Ashley Nelson, assistant professor of immunology research in the Department of Pediatrics at Weill Cornell Medicine, has received a 2023 Hartwell Individual Biomedical Research Award from The Hartwell Foundation.
TeraPore Technologies, co-founded by Rachel Dorin, Ph.D. ’13, and its novel nanofiltration products are changing how the pharmaceutical industry is reducing risk of harmful virus contamination in biological drugs.
Jeannine Gerhardt, an assistant professor of stem cell biology in obstetrics and gynecology and in reproductive medicine at Weill Cornell Medicine, has received a five-year, $2.1 million grant for the study of repetitive DNA and RNA sequences and the mechanisms by which they cause cell dysfunction and diseases.
A dual-chamber wireless pacemaker provides reliable performance over three months, bolstering evidence for this new option, according to results from a multi-center international clinical trial co-led by a Weill Cornell Medicine investigator.
Nutritionists generally advise everyone to eat more dietary fiber, but a new study suggests that its effects on health can vary, suggesting that recommendations should be tailored to each individual’s gut microbiome.
Intimate partner violence is notoriously underreported and correctly diagnosed at hospitals only around a quarter of the time, but a new method provides a more realistic picture of which groups of women are most affected, even when their cases go unrecorded.
The 2024 CROPPS Annual Meeting and Symposium held in October in the Sonoran Desert region of Arizona provided an ideal stage for discussions on sustainable agriculture in hot, dry environments.